Evaluation of Objective Clinical Response (CR/PR/SD) [clinicaltrials_resource:NCT00003222/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Evaluation of Objective Clinical Response (CR/PR/SD) [clinicaltrials_resource:NCT00003222/outcome/1]
Bio2RDF identifier
NCT00003222/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00003222/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Analysis of this outcome measu ...... least 6 subjects on each arm.
The analysis of this outcome m ...... nadequate sample availability.
The analysis of this outcome m ...... luded 13 subjects in each arm.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Weeks 0-6,12; Months 6,12 and 24
type [clinicaltrials_vocabulary:type]
alternate
Evaluation of Objective Clinical Response (CR/PR/SD)
@en
identifier
clinicaltrials_resource:NCT00003222/outcome/1
title
The primary end point for this ...... herwise involved in the study.
@en
type
label
Evaluation of Objective Clinic ...... esource:NCT00003222/outcome/1]
@en